4//SEC Filing
MILNE GEORGE M JR 4
Accession 0000899243-23-009179
CIK 0001658551other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 8:25 PM ET
Size
6.8 KB
Accession
0000899243-23-009179
Insider Transaction Report
Form 4
MILNE GEORGE M JR
Director
Transactions
- Sale
Common Stock
2023-03-16$32.45/sh−1,916$62,172→ 862,021 total - Sale
Common Stock
2023-03-16$31.86/sh−33,084$1,053,901→ 863,937 total
Footnotes (3)
- [F1]These sales were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on November 16, 2022.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.30 to $32.29. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.30 to $32.93. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Documents
Issuer
Amylyx Pharmaceuticals, Inc.
CIK 0001658551
Entity typeother
Related Parties
1- filerCIK 0001179552
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 8:25 PM ET
- Size
- 6.8 KB